Ironwood Pharmaceuticals, Inc.
Treatment of Constipation-Predominant Irritable Bowel Syndrome
Last updated:
Abstract:
The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
Status:
Application
Type:
Utility
Filling date:
20 Dec 2021
Issue date:
14 Apr 2022